AC
JNJ icon

Armistice Capital’s Johnson & Johnson JNJ Stock Holding History

Armistice Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75,218
Closed -$11.5M – 363
2025
Q2 		$11.5M Buy
+75,218
New +$11.6M 0.2% 65
2023
Q4 		– Sell
-134,378
Closed -$20.9M – 331
2023
Q3 		$20.9M Sell
134,378
-325,622
-71% -$53.7M 0.32% 54
2023
Q2 		$76.1M Buy
460,000
+2,117
+0.5% +$342K 1.1% 13
2023
Q1 		$71M Buy
457,883
+397,883
+663% +$64.2M 1.02% 23
2022
Q4 		$10.6M Sell
60,000
-20,000
-25% -$3.45M 0.18% 73
2022
Q3 		$13.1M Sell
80,000
-176,000
-69% -$29.8M 0.23% 68
2022
Q2 		$45.4K Buy
+256,000
New +$45.6M 0.79% 31

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Armistice Capital's JNJ Position: Q3 2025 in Review

Armistice Capital sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 75,218 shares — an estimated $11.5M sold.

Armistice Capital first reported a position in JNJ in Q2 2022 and held it in 7 quarters. The position peaked at $76.1M in Q2 2023. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Armistice Capital reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Armistice Capital sold 75,218 Johnson & Johnson shares in Q3 2025, an estimated $11.5M.
  • Armistice Capital first reported a position in Johnson & Johnson in Q2 2022 and held it in 7 quarters.
  • Armistice Capital's Johnson & Johnson position peaked at $76.1M in Q2 2023.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.